innate-pharma.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IPHA
High competition in immuno-oncology and the risks of clinical failures are putting pressure on quotes, however, the EBITDA financial metric on the GURU.Markets time chart shows that the figure remains around 0.00. The business resilience of Innate Pharma S.A. (IPHA) is based on licensing payments and the NK-cell activation platform, while strategic alliances with pharma behemoths provide synergy in drug development.
Innate Pharma - rincian analitis lan metrik utama (IPHA)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Innate Pharma S.A.|IPHA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Innate Pharma SA|IPHA - Utang perusahaan|Rasio utang marang nilai buku Innate Pharma|IPHA - Utang jangka dawa perusahaan|Utang jangka cendhak Innate Pharma|Likuiditas kritis innate-pharma.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
IPHA - Penghasilan resik|Bathi resik mangsa ngarep Innate Pharma S.A.|IPHA - Pangali P/E|Pangali mangsa ngarep rega marang bathi innate-pharma.com|IPHA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Innate Pharma|IPHA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Innate Pharma|IPHA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan innate-pharma.com|IPHA - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Innate Pharma S.A.
Analisis kabeh metrik perusahaan:Innate Pharma S.A - IPHA
As a European leader in the development of NK-cell antibodies for cancer treatment, Innate Pharma S.A. depends on the effective commercialization of its innovations. The company's consolidated EBITDA reflects operating cash flow before depreciation and taxes, allowing investors to use this chart to assess the business's actual ability to generate cash and promptly identify risks of declining operating margins.
Pesaing Innate Pharma S.A. (IPHA)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Group Inc REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PYXS (Pyxis Oncology, Inc.) - Bathi operasional sadurunge amortisasi|cgen.com (CGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi iobiotech.com (IOBT)|Bathi operasional sadurunge ngurangi amortisasi STRO|INKT - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi HOWL (Werewolf Therapeutics)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi IMMX|Bathi operasional EBITDA ALXO (ALX Oncology)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CUE|PDS Biotechnology Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Liminatus - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LVTX (LAVA Therapeutics NV) - Bathi operasional EBITDA|Bathi operasional EBITDA nextcure.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Leap Therapeutics, Inc. (LPTX)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Corp (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|Gritstone Bio - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi kinetabio.com KA|NexImmune (NEXI) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi TSBX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Vaccinex, Inc|Bathi operasional sadurunge amortisasi HARP (Harpoon Therapeutics Corp)
